Literature DB >> 3942377

Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea.

J T Sharp, W S Druz, V R Kondragunta.   

Abstract

Patients with severe obesity and obstructive sleep apnea (OSA) have been shown to have abnormalities in respiratory muscle function and respiratory control. The present study was done to evaluate diaphragmatic function and the diaphragm fiber-length-compensating reflex in morbidly obese patients with OSA (1). Twelve normal subjects and 13 morbidly obese patients with OSA were studied in recumbent and upright positions. In the normal subjects, the diaphragm fiber-length-compensating reflex operated normally causing the diaphragm's inspiratory EMG to increase when the diaphragm's fibers shortened with assumption of the upright position. However, 8 of the 13 obese patients with OSA showed a decrease rather than an increase in the inspiratory diaphragmatic EMG on assuming the upright posture. Further data indicate greater diaphragmatic efficiency in the upright than in the supine position in a majority of the obese patients, a reversal of the normal response. Two possible explanations of these observations are: an abnormality of central respiratory control in obese patients with OSA and overstretching of the diaphragm in the recumbent obese patient. The observation of reduced maximal transdiaphragmatic pressures in the recumbent position in some of the obese patients with OSA supports the second explanation. Diaphragmatic overstretching may be an important mechanism in the development of hypoventilation in the morbidly obese.

Entities:  

Mesh:

Year:  1986        PMID: 3942377     DOI: 10.1164/arrd.1986.133.1.32

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

1.  Effects of body composition and adipose tissue distribution on respiratory function in elderly men and women: the health, aging, and body composition study.

Authors:  Andrea P Rossi; Nora L Watson; Anne B Newman; Tamara B Harris; Stephen B Kritchevsky; Douglas C Bauer; Suzanne Satterfield; Bret H Goodpaster; Mauro Zamboni
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-04-15       Impact factor: 6.053

2.  Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Giovanni Barausse; Davide Gatti; Marcello Ferrari; Sara Pieropan; Dania Sabbagh; Silvano Adami
Journal:  Clin Rheumatol       Date:  2013-09-20       Impact factor: 2.980

Review 3.  Altered respiratory physiology in obesity.

Authors:  Krishnan Parameswaran; David C Todd; Mark Soth
Journal:  Can Respir J       Date:  2006 May-Jun       Impact factor: 2.409

4.  Effect of posture on inspiratory muscle electromyogram response to hypercapnia.

Authors:  T Wanke; H Lahrmann; D Formanek; H Zwick
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

5.  Obesity Hypoventilation Syndrome.

Authors:  Safal Shetty; Sairam Parthasarathy
Journal:  Curr Pulmonol Rep       Date:  2015-03-01

6.  A Management Guideline for Obesity-Hypoventilation Syndromes.

Authors:  Shyam Subramanian; Kingman P. Strohl
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

Review 7.  Altered resting and exercise respiratory physiology in obesity.

Authors:  Akshay Sood
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

8.  Unanticipated Nocturnal Oxygen Requirement during Positive Pressure Therapy for Sleep Apnea and Medical Comorbidities.

Authors:  Safal Shetty; Aaron Fernandes; Sarah Patel; Daniel Combs; Michael A Grandner; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

9.  Diaphragmatic function in patients on continuous ambulatory peritoneal dialysis.

Authors:  T Wanke; M Auinger; H Lahrmann; M Merkle; D Formanek; K Irsigler; H Zwick
Journal:  Lung       Date:  1994       Impact factor: 2.584

Review 10.  Environmental perturbations: Obesity.

Authors:  Stephanie A Shore
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.